Immunohistochemical detection of p53 protein in human prostatic cancer

Journal of Urology

Volumn 152, Issue 4, 1994, Pages 1297-1301

  Henke, R P ^a   Kruger, E ^a   Ayhan, N ^a   Hubner, D ^a   Hammerer, P ^a   Huland, H ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

prognosis; prostatic neoplasms; protein p53

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CANCER GROWTH; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATECTOMY; PROTEIN ANALYSIS; TUMOR CELL CULTURE; TUMOR VOLUME;

EID: 0027934774     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(17)32571-5     Document Type: Editorial

References (40)

1. D.P. Lane L.V. Crawford T antigen is bound to a host protein in SV40 transformed cells Nature (London) 278 1979 261
2. D.I.H. Linzer A.J. Levine Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells Cell 17 1979 43
3. M. Isobe B.S. Emanuel D. Givol M. Oren C.M. Croce Localization of gene for human p53 tumour antigen to band 17pl3 Nature (London) 320 1986 84
4. C. Miller T. Mohandas D. Wolf M. Prococimer V. Rotter H.P. Koeffler Human p53 gene is localised to short arm of chromosome 17 Nature (London) 319 1986 783
5. J. Martinez L. Georgeoff J. Martinez A.J. Levine Cellular localization and cell cycle regulation by a temperature sensitive p53 protein Genes Dev. 5 1991 151
6. D.P. Lane p53, guardian of the genome Nature (London) 358 1992
7. W.E. Mercer M. Amin G.J. Sauve E. Apella S.J. Ullrich J.W. Romano Wild type human p53 is antiproliferative in SV40-transformed hamster cells Oncogene 5 1990 973
8. L. Diller J. Kassel C.E. Nelson M.A. Gryka G. Litwak M. Gebhardt B. Bressac M. Özturk S.J. Baker B. Vogelstein S. Friend p53 functions as a cell cycle control protein in osteosarcomas Mol. Cell. Biol. 10 1990 5772
9. M.B. Kastan O. Onykwere D. Sidransky B. Vogelstein R.W. Craig Participation of p53 protein in the cellular response to DNA damage Cancer Res. 51 1991 6304
10. S.J. Ullrich W.E. Mercer E. Apella Human wild type p53 adopts a unique conformational and phosphorylation state in vivo during growth arrest of glioblastoma cells Oncogene 7 1992 1635
11. E. Yonish-Rouach D. Resnitzky J. Lotem L. Sach A. Kimchi M. Oren Wild-type p53 induces apoptosis of myeloid leukemic cells that is inhibited by interleukin-6 Nature (London) 352 1991 345
12. P. Shaw R. Bovey S. Tardy R. Sahli B. Sordat J. Costa Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line Proc. Natl. Acad. Sci. U.S.A. 89 1992 4495
13. L.A. Donehower M. Harvey B.L. Slagle M.J. McArthur C.A. Montgomery Jr. J.S. Butei A. Bradley Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours Nature (London) 356 1992 215
14. J.M. Nigro S.J. Baker A.C. Preisinger J.M. Jessup R. Hostette K. Cleary S.H. Bigner N. Davidson S. Baylin P. Devilee Mutations in the p53 gene occur in diverse human tumour types Nature (London) 342 1989 705
15. M. Hollstein D. Sidransky B. Vogelstein C.C. Harris p53 mutations in human cancers Science 253 1991 49
16. N.C. Reich A.J. Levine Growth regulation of a cellular tumour antigen, p53, in nontransformed cells Nature (London) 308 1984 199
17. C.A. Finlay P.W. Hinds T.H. Tan D. Eliyahu M. Oren A.J. Levine Activating mutations for transformation by p53 protein produced a gene product that forms an hsc70-p53 complex with an altered half-life Mol. Cell. Biol. 8 1988 531
18. R. Iggo K. Gatter J. Bartek D. Lane A.L. Harris Increased expression of mutant forms of p53 oncogene in primary lung cancer Lancet 335 1990 675
19. P.J. Effert A. Neubauer P.J. Walther E.T. Liu Alterations of the p53 gene are associated with the progression of a human prostate carcinoma J. Urol. 147 1992 789
20. W.B. Isaacs B.S. Carter C.M. Ewing Wild-type p53 suppresses growth of human prostate cancer cell lines containing mutant p53 alleles Cancer Res. 51 1991 4716
21. K. Mellon S. Thompson R.G. Charlton C. Marsh M. Robinson D.P. Lane A.L. Harris C.H.W. Horne D.E. Neal p53, c-erbB-2 and the epidermal growth factor receptor in the benign and malignant prostate J. Urol. 147 1992 496
22. S.J. Thompson K. Mellon G.G. Charlton C. Marsh M. Robinson D.E. Neal P53 and ki-67 immunoreactivity in human prostate cancer and benign hyperplasia Br. J. Urol. 69 1992 609
23. Y. Soini P. Pääkkö K. Nuorva D. Kamel D.P. Lane K. Vähäkangas Comparative analysis of p53 protein immunoreactivity in prostatic, lung and breast carcinomas Virchows Archiv [A] 421 1992 223
24. T. Visakorpi O.P. Kallioniemi A. Heikkinen T. Koivula J. Isola Small subgroup of aggressive, highly proliferative prostatic carcinomas defined by p53 accumulation J. Natl. Cancer Inst. 84 1992 883
25. P.J. Van Veldhuizen R. Sadasivan F. Garcia M.S. Austenfeld R.L. Stephens Mutant p53 expression in prostate carcinoma Prostate 22 1993 23
26. J.E. McNeal E.A. Redwine F.S. Freiha T.S. Stamey Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread Am. J. Surg. Pathol. 12 1988 897
27. D.F. Gleason Veterans Administration Cooperative Urological Research Group: Histologic grading and clinical staging of prostate carcinoma M. Tannenbaum Urologie Pathology: The Prostate 1977 Lea and Febiger Philadelphia 171 197
28. P. Hermanek L.H. Sobin 2nd revision TNM classification 4th edition 1992 Springer Berlin, Heidelberg, New York 141 144
29. H.P. Schmid J.E. McNeal An abbreviated standard procedure for accurate tumor volume estimation in prostate cancer Am. J. Surg. Pathol. 16 1992 184
30. M. Rentrop B. Knapp H. Winter J. Schweizer Aminoal-kylsilane-treated glass slides as support for in situ hybridization of keratin cDNAs to frozen tissue sections under varying fixation and pretreatment conditions Histochem. J. 18 1986 271
31. S.R. Shi M.E. Key K.L. Kaira Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections J. Histochem. Cytochem. 39 1991 741
32. S.M. Hsu L. Raine H. Fänger Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures J. Histochem. Cytochem. 29 1981 577
33. B.-J.M. Kerns P.A. Jordan M.-B.H. Moore P.A. Humphrey A. Berchuck M.F. Kohler R.C. Bast J.D. Iglehart J.R. Marks p53 overexpression in formalin-fixed, paraffin-embedded tissue detected by immunohistochemistry J. Histochem. Cytochem. 40 1992 1047
34. Y. Kawasaki T. Monden H. Morimoto M. Murotani Y. Miyoshi T. Kobayashi T. Shimano T. Mori Immunohistochemical study of p53 expression in microwave-fixed, paraffin-embedded sections of colorectal carcinoma and adenoma Am. J. Clin. Pathol. 97 1992 244
35. P.J. Van Veldhuizen R. Sadasivan R. Cherian T. Dwyer R.L. Stephens p53 expression in incidental prostatic cancer Am. J. Med. Sci. 305 1993 275
36. P.J. Effert R.H. McCoy P.J. Walther E.T. Liu p53 genealterations in human prostate carcinoma J. Urol. 150 1993 257
37. R. Bookstein D. MacGrogan S.G. Hilsenbeck F. Sharkey D.C. Allred p53 is mutated in a subset of advanced-stage prostate cancers Cancer Res. 53 1993 3369
38. U.M. Moll G. Riou A.J. Levine Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion Proc. Natl. Acad. Sci. U.S.A. 89 1992 7262
39. J.E. McNeal Origin and development of carcinoma in the prostate Cancer 23 1969 24
40. L.P. Fielding C.M. Fenoglio-Preiser L.S. Freedman The future of prognostic factors in outcome prediction for patients with cancer Cancer 70 1992 2367